Pharmamarketeer
wet- en regelgeving

Sanofi’s dengue shot Dengvaxia wins FDA priority review despite controversial past

31 oktober 2018
FiercePharma

The FDA accepted Sanofi’s approval application for Dengvaxia, the dengue vaccine at the center of a safety scandal earlier this year in the Philippines. Now, the agency is set to decide on the vaccine for U.S. approval by May 1, 2019.

Reageer

Ook interessant voor je

Medhc-fases-banner
Advertentie(s)